Profiles of Drug Substances, Excipients and Related Methodology

Volumes in this widely revered series present comprehensive reviews of drug substances and additional materials, with critical review chapters that summarize information related to the characterization of drug substances and excipients. This organizational structure meets the needs of the pharmaceutical community and allows for the development of a timely vehicle for publishing review materials on this topic.

The scope of the Profiles series encompasses review articles and database compilations that fall within one of the following six broad categories: Physical profiles of drug substances and excipients; Analytical profiles of drug substances and excipients; Drug metabolism and pharmacokinetic profiles of drug substances and excipients; Methodology related to the characterization of drug substances and excipients; Methods of chemical synthesis; and Reviews of the uses and applications for individual drug substances, classes of drug substances, or excipients.

Presents comprehensive reviews covering all aspects of drug development and formulation of drugsProfiles creatine monohydrate and fexofenadine hydrochloride, as well as five othersMeets the information needs of the drug development community

1. Buclizine Gamal A. E. Mostafa and Abdullah A. Al-Badr
2. Chitin Nidal H. Daraghmeh, Babur Z. Chowdhry, Stephen A. Leharne, Mahmoud M. Al Omari and Adnan A. Badwan
3. EZETIMIBE Maria L.A.D Lestari, Febri Ardiana and Gunawan Indrayanto
4. Gemifloxacin Badraddin M.H. Al-Hadiya¹ and Ashraf M.M. Mahmoud
5. Glimepiride Maria L.A.D Lestari and Gunawan Indrayanto
6. Lornoxicam Mahrous O. Ahmed, Abdullah A. Al-Badr
7. Magnesium Silicate Iyad Rashid, Nidal H. Daraghmeh, Mahmoud M. Al Omari, Babur Z. Chowdhry, Stephen A. Leharne _, Hamdallah A. Hodali and Adnan A. Badwan
8. Tadalafil Alaa A.-M. Abdel-Aziz, Yousif A. Asiri, Adel S. El-Azab, Mohamed A. Al-Omar and Takehisa Kunieda
9. Direct Crystallization of Enantiomers and Dissociable Diastereomers Harry G. Brittain
10. Cocrystal Systems of Pharmaceutical Interest: 2009 Harry G. Brittain